National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Understanding Cancer Series: Genetic Variation (SNPs)
< Back to Main
    Posted: 01/28/2005    Reviewed: 09/01/2006
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
PDF Version  View/Print PDF
PowerPoint Version  View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Slide 34 : SNPs and Drug Interactions previousnext

SNPs may also explain why some patients respond well to a specific drug treatment, while others have minimal or no response. SNPS may also be involved when patients have different side effects in response to the same drug.

Many proteins interact with the drug - involved in its transportation throughout the body, absorption into tissues, metabolism into more active forms or toxic by-products, and excretion. If a patient has SNPs in any one or more of these proteins, they may alter the time the body is exposed to active forms of the drug or any of its toxic byproducts.

SNPs and Drug Interactions

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov